1. Home
  2. ACOG vs TAYD Comparison

ACOG vs TAYD Comparison

Compare ACOG & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • TAYD
  • Stock Information
  • Founded
  • ACOG 2000
  • TAYD 1955
  • Country
  • ACOG Canada
  • TAYD United States
  • Employees
  • ACOG N/A
  • TAYD N/A
  • Industry
  • ACOG
  • TAYD Industrial Machinery/Components
  • Sector
  • ACOG
  • TAYD Industrials
  • Exchange
  • ACOG Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • ACOG 80.3M
  • TAYD 96.0M
  • IPO Year
  • ACOG N/A
  • TAYD N/A
  • Fundamental
  • Price
  • ACOG $7.43
  • TAYD $37.03
  • Analyst Decision
  • ACOG Strong Buy
  • TAYD
  • Analyst Count
  • ACOG 1
  • TAYD 0
  • Target Price
  • ACOG $20.00
  • TAYD N/A
  • AVG Volume (30 Days)
  • ACOG 80.6K
  • TAYD 21.3K
  • Earning Date
  • ACOG 05-15-2025
  • TAYD 03-28-2025
  • Dividend Yield
  • ACOG N/A
  • TAYD N/A
  • EPS Growth
  • ACOG N/A
  • TAYD 1.48
  • EPS
  • ACOG N/A
  • TAYD 2.50
  • Revenue
  • ACOG N/A
  • TAYD $42,796,782.00
  • Revenue This Year
  • ACOG N/A
  • TAYD N/A
  • Revenue Next Year
  • ACOG N/A
  • TAYD N/A
  • P/E Ratio
  • ACOG N/A
  • TAYD $14.76
  • Revenue Growth
  • ACOG N/A
  • TAYD N/A
  • 52 Week Low
  • ACOG $3.75
  • TAYD $29.50
  • 52 Week High
  • ACOG $7.00
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • TAYD 70.65
  • Support Level
  • ACOG N/A
  • TAYD $30.53
  • Resistance Level
  • ACOG N/A
  • TAYD $38.02
  • Average True Range (ATR)
  • ACOG 0.00
  • TAYD 1.52
  • MACD
  • ACOG 0.00
  • TAYD 0.66
  • Stochastic Oscillator
  • ACOG 0.00
  • TAYD 87.66

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: